Neurology & Neurosurgery Research
EAISE Study
Proof of Concept Study to Assess the Safety and Efficacy of Elezanumab in Acute Ischemic Stroke
AGE: 30 to 90 years
SEX AT BIRTH: All
SEX AT BIRTH: All
TYPE: Investigational Drug Study
CONDITION: Acute Ischemic Stroke
CONDITION: Acute Ischemic Stroke
HEALTHY PARTICIPANTS: No
LOCATION: UH Cleveland Medical Center
LOCATION: UH Cleveland Medical Center
Learn More About This Research Study
For more information, please contact study coordinator, Mary Andrews at 216-844-2386 and leave a message or complete the online form below.
Study Purpose
The purpose of this study is to evaluate if the investigational drug, elezanumab, is safe and able to improve cognitive and/or motor functioning in an individual following the occurrence of acute ischemic stroke.
Who Can Participate
Participants who were diagnosed with an acute ischemic stroke maybe eligible for this study.
Study ID
- STUDY20200610